Partner Headlines - CLVS

  1. Gilead Slips As Former Bull Turns Bearish On Hep C Business

    TalkMarkets
  2. Benzinga's Top Initiations

    Benzinga
  3. Clovis Oncology Receives Notification of PDUFA Extension for ...

    Benzinga
  4. Benzinga's M&A Chatter for Tuesday December 1, 2015

    Benzinga
  5. Kyle Bass Builds Bull Case for Clovis Oncology

    GuruFocus
  6. Clovis Oncology Continues Lower After Consolidation

    Benzinga
  7. KaloBios, Valeant Lead Week's 5 Top Drug Stock Gainers

    IBD
  8. Morning Market Losers

    Benzinga
  9. Benzinga's Top Downgrades

    Benzinga
  10. Benzinga's Top #PreMarket Losers

    Benzinga
  11. Biotech Clovis Oncology

    IBD
  12. Mid-Afternoon Market Update: Dow Surges More Than 200 Points; ...

    Benzinga
  13. Mid-Day Market Update: Starwood Drops Following Announcement ...

    Benzinga
  14. Clovis Stumbles, AstraZeneca Leads Cancer Drug Race

    IBD
  15. What The FDA Gave Clovis Oncology In June 2013, It Has Taken ...

    Benzinga
  16. Mid-Morning Market Update: Markets Edge Higher; Marriott To Acquire ...

    Benzinga
  17. Morning Market Losers

    Benzinga
  18. Genomics Out Of 'Caveman Era,' But Still A Ways To Go

    IBD
  19. Clovis Oncology Announces U.S. and E.U. Regulatory Milestones ...

    Benzinga
  20. Clovis Oncology Announces Data Presentations at 16th World Conference ...

    Benzinga
  21. Clovis Oncology Completes US, EU Regulatory Submissions for Rociletinib ...

    Benzinga
  22. Benzinga's Top Upgrades

    Benzinga
  23. Clovis Oncology Announces Exercise in Full of Underwriters' Option ...

    Benzinga
  24. Clovis Oncology Initiates Rolling NDA Submission to the FDA for ...

    Benzinga
  25. Morning Market Losers

    Benzinga
  26. J.P. Morgan's 3 Biotechnology Picks

    GuruFocus
  27. Clovis Technology Gets Big Boost From Goldman Upgrade

    IBD
  28. Benzinga's Volume Movers

    Benzinga
  29. Morning Market Gainers

    Benzinga
  30. Benzinga's Top Upgrades

    Benzinga
  31. Benzinga's Top #PreMarket Gainers

    Benzinga
  32. Goldman Sachs Upgrades Clovis Oncology To Buy

    Benzinga
  33. Earnings Scheduled For February 25, 2015

    Benzinga
  34. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  35. Morning Market Losers

    Benzinga
  36. Clovis Oncology Enters Into Oncology Clinical Trial Collaboration ...

    Benzinga
  37. UPDATE: Stifel Reiterates On Clovis Oncology Following 3Q14 LPS

    Benzinga
  38. Morning Market Losers

    Benzinga
  39. Biotech Enters Reporting Season With Large Caps Central To Sector ...

    Benzinga
  40. US Stock Futures Flat Ahead Of Manufacturing PMI

    Benzinga
  41. Market Wrap For June 5: Markets Positive Before Friday's Employment ...

    Benzinga
  42. UPDATE: Stifel Upgrades Clovis Oncology On Favorable Risk/Reward

    Benzinga
  43. Market Wrap For June 4: Markets Slightly Higher On Light Volume, ...

    Benzinga
  44. Citi Downgrades Clovis, Rates It As High Risk

    Benzinga
  45. Benzinga's Volume Movers

    Benzinga
  46. Benzinga's Top #PreMarket Gainers

    Benzinga
  47. UPDATE: Clovis Oncology Shares Rise 12% Premarket on Positive ...

    Benzinga
  48. US Stock Futures Rise; GDP, Jobless Claims Data In Focus

    Benzinga
  49. Mid-Morning Market Update: Markets Open Higher; Francesca's Issues ...

    Benzinga
  50. Benzinga's Top Initiations

    Benzinga
  51. Mid-Day Market Update: SodaStream Drops After Weak Outlook; Beam ...

    Benzinga
  52. Mid-Morning Market Update: Markets Open Lower; Lululemon Lowers ...

    Benzinga
  53. Benzinga's Top #PreMarket Gainers

    Benzinga
  54. Clovis Oncology Announces 2014 Objectives, Financial Guidance ...

    Benzinga
  55. What The Top Stocks Of 2013 Had In Common

    IBD
  56. Clovis Oncology CO-1686 Clinical Data Accepted as Oral Presentation ...

    Benzinga
  57. Clovis Oncology Announces 2M Share Offering by Selling Stockholders ...

    Benzinga
  58. Benzinga's M&A Chatter for Tuesday November 19, 2013

    Benzinga
  59. Why Clovis Oncology Was The Short Trade Of The Day

    Benzinga
  60. UPDATE: H.C. Wainwright nitiates on Clovis Oncology On Prospects ...

    Benzinga
  61. Mid-Morning Market Update: Markets Mixed; Merck Profit Beats ...

    Benzinga
  62. Clovis Oncology's CO-1686 Demonstrates Promising Clinical Activity ...

    Benzinga
  63. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD
  64. QIAGEN Announces Partnership With Clovis Oncology to Co-develop ...

    Benzinga
  65. Mid-Day Market Update: Dow Falls Over 100 Points; Active Network ...

    Benzinga
  66. Mid-Morning Market Update: Markets Open Lower; Cal-Maine Q1 Net ...

    Benzinga
  67. Mid-Day Market Update: US Stocks Turn Higher; MAKO Surgical Shares ...

    Benzinga
  68. Mid-Morning Market Update: Markets Slip; AutoZone Q4 Net Profit ...

    Benzinga
  69. Morning Market Losers

    Benzinga
  70. Benzinga's M&A Chatter for Tuesday September 24, 2013

    Benzinga
  71. Benzinga's Top Initiations

    Benzinga
  72. Benzinga's M&A Chatter for Tuesday September 17, 2013

    Benzinga
  73. UPDATE: Stifel Initiates Coverage on Clovis Oncology, Awaiting ...

    Benzinga
  74. These ETFs House The Next Biotech Takeover Targets

    Benzinga
  75. Mid-Day Market Update: Markets Slow Their Rally; JC Penney Spikes ...

    Benzinga
  76. Mid-Morning Market Update: Markets Continue Cautious Rally; Jefferies ...

    Benzinga
  77. Benzinga's Top Pre-Market Losers

    Benzinga
  78. Health Care Sector Wrap

    FoxBusiness
  79. Health Care Sector Wrap

    FoxBusiness
  80. Clovis Oncology and Array BioPharma Announce Agreement to Discover ...

    Benzinga
  81. Clovis Oncology Announces FDA Acceptance of Investigational New ...

    Benzinga
  82. End-of-Day Market Summary for January 18, 2012

    Benzinga
  83. UPDATE: JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
  84. JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
  85. JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
Trading Center